Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy - Wikidata - awgldk - TriplyDB

Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy

Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy

http://www.wikidata.org/entity/Q35844633

about

Gene therapy for the treatment of heart failure: promise postponed VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.VEGF-B promotes recovery of corneal innervations and trophic functions in diabetic mice.Cardiovascular Gene Therapy: Past, Present, and Future.Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease.Current Methods in Cardiac Gene Therapy: Overview.Cardiac gene therapy with adeno-associated virus-based vectors.Use of Adeno-Associated Virus Vector for Cardiac Gene Delivery in Large-Animal Surgical Models of Heart Failure.Production and Characterization of Vectors Based on the Cardiotropic AAV Serotype 9.Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation.Long-term Intake of Pasta Containing Barley (1-3)Beta-D-Glucan Increases Neovascularization-mediated Cardioprotection through Endothelial Upregulation of Vascular Endothelial Growth Factor and Parkin.Gene Therapy in Heart Failure.Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure.Clinical management of dilated cardiomyopathy: current knowledge and future perspectives.Loss of VEGFB and its signaling in the diabetic heart is associated with increased cell death signaling.Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective.MicroRNA-30c suppresses the pro-fibrogenic effects of cardiac fibroblasts induced by TGF-β1 and prevents atrial fibrosis by targeting TGFβRII.Treatment with placental growth factor attenuates myocardial ischemia/reperfusion injury

P2860

Q36953151-D7914314-C5D0-4FE0-8ED5-20731543FC73 Q37469455-02E08D37-00B8-4E84-B4D8-F66B0B3D511A Q37587659-8491387F-1443-40A6-9FDE-234D99B5A7CF Q38733395-DB4C6B89-3A58-4FBF-80B1-81958D86E286 Q38773475-5881D744-9A8F-4E0F-9150-881F44B7F921 Q38788217-FD3503FE-184A-40B5-AA54-D81C53D6F44A Q39124456-9DA40459-5EE9-4B84-A786-83F761F6FB5A Q39447181-84D0ABDF-A97C-407F-BE9C-13D7EE528E1E Q40445316-E3CB19DD-EA1B-4FDE-AB2D-9ED3BE0DE249 Q41150386-C2ABCE1A-EF8D-4A31-AA48-4CA8E0693769 Q42677423-79F138D2-4BFD-465D-981D-5A8CA5F444BB Q45861410-FC8772B6-52BF-4302-B60B-B011C3DCDB97 Q47215993-31792711-D003-410D-A913-4EAF8ED592F7 Q48308293-45656984-4DB1-467E-AA6B-20B8E9E7ABA3 Q51095061-0B03E775-0EEA-4D20-A4E2-6C67B517EC05 Q51760757-6E2D3DC4-189C-4D83-B2A8-9FB0C2F80A7C Q52658507-0B38682F-3B13-43A0-B719-5C4F891F83C2 Q58744453-A40D3921-43DC-42D7-A098-59A6FAF51FCB

P2860

Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy

http://www.wikidata.org/entity/Q35844633

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Intracoronary Cytoprotective G ...... odel of Dilated Cardiomyopathy

@ast

Intracoronary Cytoprotective G ...... odel of Dilated Cardiomyopathy

@en

type

label

Intracoronary Cytoprotective G ...... odel of Dilated Cardiomyopathy

@ast

Intracoronary Cytoprotective G ...... odel of Dilated Cardiomyopathy

@en

prefLabel

Intracoronary Cytoprotective G ...... odel of Dilated Cardiomyopathy

@ast

Intracoronary Cytoprotective G ...... odel of Dilated Cardiomyopathy

@en

P1433

Q35844633-BCAB3290-0D07-4C00-AC7F-9608414CB04B

P1476

Q35844633-720B7ED9-E267-4921-806D-E61CD9AC4852

P2093

Q35844633-02441D59-2773-4DE2-B3F0-34272E23B6CD

Q35844633-0C9EFEE0-B26A-465C-AD1F-BEF946F0B988

Q35844633-0CA5081D-B2F7-4A62-BD2A-B39AA6BA320B

Q35844633-2872581F-EC11-47F6-84F7-E9ACB7CE169F

Q35844633-3D1C382C-C6BB-42C1-9B8F-32EFB9ACE64F

Q35844633-5D1254DD-79B4-4060-9C5E-40853D383E2B

Q35844633-731348CB-A04B-4031-B634-5808DD7763AC

Q35844633-8754007E-65CC-42C8-8A16-76AF2A750C00

Q35844633-8ECE45D5-4914-4F79-9BCF-9DEB560D60CF

Q35844633-A3E374A0-19C0-4BAB-AD64-0F6248F9A1DC

P2860

Q35844633-01C9D9E5-41DA-439A-A9E7-67184E707FBD

Q35844633-0ADB0E05-D009-44FA-B442-5012B732DF12

Q35844633-0E3E4C9F-7730-4FD0-9D16-FFAF07CDEF4A

Q35844633-16CA73BA-F931-4A70-B29B-86ADF9C29A0A

Q35844633-1905CB88-556E-4034-81CE-3B3066C2027C

Q35844633-234DDFA1-75D6-42FB-A737-5E4936AD7468

Q35844633-2531B8C2-4F08-4FB5-9797-AB8784EEE71D

Q35844633-367E6B65-776D-4DC9-85B4-99D2417E5A86

Q35844633-374E5981-2140-4943-93CA-E7592F76E0C0

Q35844633-40D29E1A-AED8-4EC1-8143-EB21DD286A8D

P304

Q35844633-C01B36ED-F656-4DE5-8D6E-12FD9DBE628E

P31

Q35844633-88AE49DD-2CAD-47FF-A292-591258D49EDF

P356

Q35844633-F67115FF-6602-46B0-AF78-471CB0B8701A

P407

Q35844633-0F7D46E0-860B-4AF8-A801-8C33402A6B93

P433

Q35844633-E7C2AD11-8BE5-4CC9-849A-68DCFEA20C41

P478

Q35844633-5F985023-CD50-4D8F-8E8B-7C32AD33AEA0

P50

Q35844633-25980F07-B9DD-4AFE-92D0-CACF25E832BD

P577

Q35844633-200026B7-D6BB-4C09-84C3-EBCF43063AA3

P5875

Q35844633-09B43E8F-C4F4-43C1-91D0-5FEB2925AF8D

P698

Q35844633-311F152F-3E86-4609-99A9-ECA0A5829D1E

P921

Q35844633-0F2E4FE4-2EF6-4445-BDC5-CE91FC11F245

P932

Q35844633-F35BEF68-1235-4B42-A03A-EE315E737159

P356

J.JACC.2015.04.071

P1433

Journal of the American College of Cardiology

P1476

Intracoronary Cytoprotective G ...... odel of Dilated Cardiomyopathy

@en

P2093

Abdelkarim Sabri

http://www.w3.org/2001/XMLSchema#string

Anna M Kulczycki

http://www.w3.org/2001/XMLSchema#string

Axel Linke

http://www.w3.org/2001/XMLSchema#string

Fabio A Recchia

http://www.w3.org/2001/XMLSchema#string

Farah Shaikh

http://www.w3.org/2001/XMLSchema#string

Felix Woitek

http://www.w3.org/2001/XMLSchema#string

Harinder Singh

http://www.w3.org/2001/XMLSchema#string

Isabel Ottiger

http://www.w3.org/2001/XMLSchema#string

Jeffery C Powers

http://www.w3.org/2001/XMLSchema#string

Lorena Zentilin

http://www.w3.org/2001/XMLSchema#string

P2860

VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats

Vascular endothelial growth factor-B in physiology and disease

Heart failure gene therapy: the path to clinical practice.

Adeno-associated virus vectors as therapeutic and investigational tools in the cardiovascular system

Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart.

Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload.

c-Cbl inhibition improves cardiac function and survival in response to myocardial ischemia

Current biology of VEGF-B and VEGF-C.

A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases

Mitochondrial complex II prevents hypoxic but not calcium- and proapoptotic Bcl-2 protein-induced mitochondrial membrane potential loss

P304

139-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2015.04.071

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279963364

http://www.w3.org/2001/XMLSchema#string

P698

26160630

http://www.w3.org/2001/XMLSchema#string

P921

P932

4499859

http://www.w3.org/2001/XMLSchema#string